David Pelizzon - Orthopediatrics Corp Independent Director
| KIDS Stock | USD 32.83 1.02 3.21% |
Director
Mr. David R. Pelizzon is Director of the Company. Since 2011. Mr. Pelizzon was nominated pursuant to the Stockholders Agreement with Squadron Capital LLC. Mr. Pelizzon is the President of Squadron and a member of its Managing Committee, positions he has held since 2008. Prior to joining Squadron, Mr. Pelizzon was the Managing Director of Precision Edge Surgical Products Company from 2005 to 2008. Mr. Pelizzon is a retired U.S. Army officer who served nearly 30 years on active duty in airborne and special operations units. Mr. Pelizzon is a graduate of the U.S. Military Academy and earned advanced degrees from Harvard University and the U.S. Naval War College. We believe Mr. Pelizzons leadership and management experience qualify him to serve on our board of directors. since 2011.
| Age | 62 |
| Tenure | 13 years |
| Address | 2850 Frontier Drive, Warsaw, IN, United States, 46582 |
| Phone | 574 268 6379 |
| Web | https://www.orthopediatrics.com |
Orthopediatrics Corp Management Efficiency
The company has return on total asset (ROA) of (0.0372) % which means that it has lost $0.0372 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0555) %, meaning that it created substantial loss on money invested by shareholders. Orthopediatrics Corp's management efficiency ratios could be used to measure how well Orthopediatrics Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.08 in 2024. Return On Capital Employed is likely to drop to -0.07 in 2024. At this time, Orthopediatrics Corp's Total Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 255.9 M in 2024, whereas Total Current Assets are likely to drop slightly above 122.2 M in 2024.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Donald Berwick | National Research Corp | 71 | |
| Martiny Harris | HealthStream | 59 | |
| JoAnn Martin | National Research Corp | 63 | |
| P Shastri | National Research Corp | 65 | |
| Harald Arnet | National Research Corp | N/A | |
| Martin Harris | HealthStream | 61 | |
| William Stead | HealthStream | 69 | |
| Thompson Dent | HealthStream | 68 | |
| Barbara Mowry | National Research Corp | 70 | |
| Dale Polley | HealthStream | 67 | |
| Deborah Tate | HealthStream | 61 | |
| Frank Gordon | HealthStream | 55 | |
| Michael Shmerling | HealthStream | 62 | |
| Jeffrey McLaren | HealthStream | 51 | |
| Savita Acharya | National Research Corp | 41 | |
| John Nunnelly | National Research Corp | 65 | |
| Kjersti Kanne | National Research Corp | N/A | |
| Brita Eilertsen | National Research Corp | 53 | |
| Linda Rebrovick | HealthStream | 62 | |
Management Performance
| Return On Equity | -0.0555 | ||||
| Return On Asset | -0.0372 |
Orthopediatrics Corp Leadership Team
Elected by the shareholders, the Orthopediatrics Corp's board of directors comprises two types of representatives: Orthopediatrics Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Orthopediatrics. The board's role is to monitor Orthopediatrics Corp's management team and ensure that shareholders' interests are well served. Orthopediatrics Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Orthopediatrics Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Pelizzon, Independent Director | ||
| Marie Infante, Independent Director | ||
| Samuel Riccitelli, Independent Director | ||
| Bryan Hughes, Independent Director | ||
| Joel Batts, Senior Affairs | ||
| David Bailey, Executive Vice President | ||
| Mark Throdahl, President CEO, Director | ||
| Alan Kozlowski, Independent Director | ||
| Joseph Hauser, President Correction | ||
| Gregory Odle, Executive Vice President | ||
| Mark Karshner, Senior Sales | ||
| Peter Armstrong, Chief Medical Officer | ||
| Terry Schlotterback, Chairman of the Board | ||
| Bernie Berry, Independent Director | ||
| Stephen Burns, Independent Director | ||
| MBAMSHA CHE, President Technologies | ||
| Daniel Gerritzen, General Counsel and Vice President of Legal and Human Resources | ||
| Kevin Unger, Independent Director | ||
| Harald Ruf, Director | ||
| Fred Hite, CFO, Director | ||
| Peter Munson, Independent Director | ||
| Oscar Moralez, Independent Director | ||
| Tram Bui, IR Contact Officer |
Orthopediatrics Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Orthopediatrics Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0555 | ||||
| Return On Asset | -0.0372 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | (0.21) % | ||||
| Current Valuation | 703.18 M | ||||
| Shares Outstanding | 23.79 M | ||||
| Shares Owned By Insiders | 31.89 % | ||||
| Shares Owned By Institutions | 71.57 % | ||||
| Number Of Shares Shorted | 982.73 K | ||||
| Price To Earning | (10.06) X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Orthopediatrics Corp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Orthopediatrics Corp's short interest history, or implied volatility extrapolated from Orthopediatrics Corp options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Orthopediatrics Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Orthopediatrics Stock please use our How to Invest in Orthopediatrics Corp guide.Note that the Orthopediatrics Corp information on this page should be used as a complementary analysis to other Orthopediatrics Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Orthopediatrics Stock analysis
When running Orthopediatrics Corp's price analysis, check to measure Orthopediatrics Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthopediatrics Corp is operating at the current time. Most of Orthopediatrics Corp's value examination focuses on studying past and present price action to predict the probability of Orthopediatrics Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthopediatrics Corp's price. Additionally, you may evaluate how the addition of Orthopediatrics Corp to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Orthopediatrics Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Orthopediatrics Corp. If investors know Orthopediatrics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Orthopediatrics Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.92) | Revenue Per Share 6.559 | Quarterly Revenue Growth 0.214 | Return On Assets (0.04) | Return On Equity (0.06) |
The market value of Orthopediatrics Corp is measured differently than its book value, which is the value of Orthopediatrics that is recorded on the company's balance sheet. Investors also form their own opinion of Orthopediatrics Corp's value that differs from its market value or its book value, called intrinsic value, which is Orthopediatrics Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Orthopediatrics Corp's market value can be influenced by many factors that don't directly affect Orthopediatrics Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Orthopediatrics Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Orthopediatrics Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orthopediatrics Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.